Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A | Linsitinib | 19.9526 | uM | 9 | 312.50 | 96.23 | 113.00 | 842.75 | 0.1341 | 0.0527 |
| MCF 10A | Linsitinib | 0.01 | uM | 9 | 312.50 | 96.23 | 556.00 | 842.75 | 0.6597 | 0.7512 |
| MCF 10A | Linsitinib | 0.031623 | uM | 9 | 312.50 | 96.23 | 981.00 | 842.75 | 1.1640 | 1.0994 |
| MCF 10A | Lapatinib | 0.01 | uM | 9 | 312.50 | 96.23 | 880.00 | 842.75 | 1.0442 | 1.0278 |
| MCF 10A | 17-AAG | 0.031623 | uM | 9 | 312.50 | 96.23 | 82.00 | 842.75 | 0.0973 | -0.0498 |
| MCF 10A | Lapatinib | 0.1 | uM | 9 | 312.50 | 96.23 | 1181.00 | 842.75 | 1.4014 | 1.2276 |
| MCF 10A | Erlotinib | 0.31623 | uM | 9 | 312.50 | 96.23 | 799.00 | 842.75 | 0.9481 | 0.9662 |
| MCF 10A | Linsitinib | 0.31623 | uM | 9 | 312.50 | 96.23 | 930.00 | 842.75 | 1.1035 | 1.0639 |
| MCF 10A | Lapatinib | 0.0016596 | uM | 9 | 312.50 | 96.23 | 1048.00 | 842.75 | 1.2435 | 1.1442 |
| MCF 10A | 17-AAG | 0.01 | uM | 9 | 312.50 | 96.23 | 170.00 | 842.75 | 0.2017 | 0.1994 |
| MCF 10A | Lapatinib | 0.031623 | uM | 9 | 312.50 | 96.23 | 1001.00 | 842.75 | 1.1878 | 1.1130 |
| MCF 10A | Lapatinib | 0.0033113 | uM | 9 | 312.50 | 96.23 | 835.00 | 842.75 | 0.9908 | 0.9941 |
| MCF 10A | 17-AAG | 0.1 | uM | 9 | 312.50 | 96.23 | 76.00 | 842.75 | 0.0902 | -0.0726 |
| MCF 10A | Linsitinib | 0.0033113 | uM | 9 | 312.50 | 96.23 | 753.00 | 842.75 | 0.8935 | 0.9293 |
| MCF 10A | Linsitinib | 3.1623 | uM | 9 | 312.50 | 96.23 | 185.00 | 842.75 | 0.2195 | 0.2322 |
| MCF 10A | Erlotinib | 0.0033113 | uM | 9 | 312.50 | 96.23 | 781.00 | 842.75 | 0.9267 | 0.9520 |
| MCF 10A | Lapatinib | 1 | uM | 9 | 312.50 | 96.23 | 635.00 | 842.75 | 0.7535 | 0.8271 |
| MCF 10A | 0 | uM | 9 | 312.50 | 96.23 | 880.00 | 842.75 | 1.0442 | 1.0278 | |
| MCF 10A | 0 | uM | 9 | 625.00 | 186.95 | 3272.00 | 2921.75 | 1.1199 | 1.0579 | |
| MCF 10A | Linsitinib | 0.1 | uM | 9 | 625.00 | 186.95 | 2267.00 | 2921.75 | 0.7759 | 0.8761 |
| MCF 10A | Lapatinib | 3.1623 | uM | 9 | 625.00 | 186.95 | 1267.00 | 2921.75 | 0.4336 | 0.6201 |
| MCF 10A | Linsitinib | 10 | uM | 9 | 625.00 | 186.95 | 794.00 | 2921.75 | 0.2718 | 0.4400 |
| MCF 10A | Erlotinib | 0.1 | uM | 9 | 625.00 | 186.95 | 2819.00 | 2921.75 | 0.9648 | 0.9820 |
| MCF 10A | Erlotinib | 19.9526 | uM | 9 | 625.00 | 186.95 | 240.00 | 2921.75 | 0.0821 | 0.0650 |
| MCF 10A | Erlotinib | 1 | uM | 9 | 625.00 | 186.95 | 448.00 | 2921.75 | 0.1533 | 0.2465 |